Peptide Drug Bioconjugation: We offer custom bioconjugation strategies, allowing drugs to be combined at the C-terminus, N-terminus, or within the peptide sequence. This service is ideal for creating peptide-based conjugates, providing a fast and efficient solution for developing novel therapeutic agents.

Manufactured with approved DMF according to the Federal Food, Drug, and Cosmetic Act for commercial distribution, ANDA registration, or clinical trials..